31 March 2021
With programs specifically developed for Oracle’s regional customer communities, this multifaceted event provides compelling sessions led by Oracle customers and industry thought leaders.
Has the global pandemic disrupted our journey or cleared the path for us in advancing clinical research? Hear from Oracle Health Sciences SVP and General Manager, Henry McNamara, as he explores the answer to this question.
Oracle Health Sciences SVP & GM
You will hear from a world-renowned bioengineer, surgeon, and investor focusing on the science of regenerative medicine, a practice that aims to refurbish diseased or damaged tissue using the body's own healthy cells. Regenerative medicine repairs and replaces damaged tissues and organs by bioprinting either entire or partial tissues and organs. These miniaturized organs, or organoids, can be engineered to create microphysiological systems and unleash new advances for drug development. These organoid systems can generate critical data to generate insights in drug toxicity, disease modeling, biomarker discovery/validation, and personalized medicine.
W.H. Boyce Professor and Director of the Wake Forest Institute for Regenerative Medicine
This session will provide an update on both Clinical One and Safety One from both a usage and directional viewpoint. A review of the roadmap and new innovation in both platforms will be covered along with the latest breakthrough on how the One platform is rethinking how to run clinical trials.
Global Vice President, Life Sciences Product Strategy, Oracle Health Sciences
Global VP for Product and Development, Oracle Health Sciences
Vice President, Safety Product Strategy, Oracle Health Sciences
Global Vice President of Development, Oracle Health Sciences
This session will review the differences between a unified platform and an integrated eClinical platform in detail and why a unified platform brings greater quality and innovation to both the front end and back end office.
Global Vice President, Life Sciences Product Strategy, Oracle Health Sciences
Enterprise Strategy Architect, Oracle Health Sciences
Vice President, Development, Oracle Health Sciences
This session will showcase the benefits of a unified approach for managing and streamlining your data.
Managing Director, Syneos Health Consulting
Exploring real-time data flows from all systems providing data sources for each study and modern technologies to deliver Unified eClinical Analytics to do away with traditional silo’d analysis views of the Data Sources.
Vice President, BDP MARS, GD, DRD, Novo Nordisk
In this session, Accenture will present a case study where they collaborated with Oracle Health Sciences to create value with an on-cloud solution implementation for one of their clients, highlighting their PV transformation journey. This presentation focuses on the key areas that led to significant improvement in process efficiency with database migration and streamlining other features, which delivered better integration and seamless user interactions.
Senior Manager, Accenture Life Sciences
Application Development Manager, Accenture
Hear our latest strategy to evolve our suite of safety products (Argus, Empirica, and Safety One Intake) to modernize the industry-leading safety applications and bring them closer to Clinical One to form one source of truth across clinical and safety.
Vice President, Safety Product Strategy, Oracle Health Sciences
Learn how to enable continuous GxP compliance of the Clinical One platform and leverage USDM’s validation accelerators to minimize your regulatory compliance burdens and fast-track innovation.
Director of Product Management, Digital and Cloud Solutions, USDM
Learn how to enable automated data cleaning and SDTM creation with integrated, pre-trained clinical AI/Machine Learning models.
Senior Vice President, Clinical Platform Strategy, Saama Technologies
Vice President, Life Science Strategy, Saama Technologies
Senior Solution Consultant, Oracle Health Sciences
In this session, Pfizer will review the pragmatic journey of AI/ML implementation in Clinical development, implementation through investments and how to embrace and capitalize with AI/ML with the Oracle partner ecosystem.
Head, A.I. and Data Science, Data Monitoring and Management, Global Product Development, Pfizer
Decentralized trials are fast becoming the new norm. This session will explore decentralized trials and the impact on Patients, Sites and Sponsors as well as examine how can we simplify adoption, and maximize this new approach to accelerate research.
Senior Vice President, Strategy and Solutions, Medable Inc.
Global Vice President, Life Sciences Product Strategy, Oracle Health Sciences
Global Vice President of Innovation, Oracle Health Sciences
Join us for a discussion about the future of pharmacovigilance operations and systems.
MD, MPH, Senior Vice President & Chief Global Pharmacovigilance Officer, Otsuka Pharmaceutical Development & Commercialization Inc.
Vice President, Safety Product Strategy, Oracle Health Sciences
In this panel session, hear what is important in next generation Clinical Trial Management needs, as well as how sponsors and CROs can collaborate on trial management and oversight within the same platform and eliminate data redundancy, integrations and status reporting needs.
CPM, MS, Senior Director, Clinical Systems & Records, Global Clinical Operations & Planning, Daiichi Sankyo, Inc.
VP, Global Clinical Monitoring, Central Monitoring Services, Syneos Health
Director, Life Sciences Product Strategy, Oracle Health Sciences
In this session, Phlexglobal's Karen Roy will take a deep dive into the power that comes with an integration of "best-of-breed" SSU, CTMS and eTMF designed to unify data and maximize efficiency of processing.
Chief Strategy Officer, Phlexglobal
Explore Oracle Health Sciences solutions and resources.